Genmab is considering Covid-19 testing mandate for employees – if guidelines allow

Genmab has yet to decide whether a corona passport or testing will be required for its employees in Denmark, though the biotech company is already testing employees in the US. CEO Jan van de Winkel is awaiting guidelines from local authorities.

Photo: Stine Bidstrup/ERH

Headlines were made last week when AP Moller - Maersk announced that it would mandate vaccinations for its office employees in Denmark and abroad.

Novo Nordisk followed in its footsteps, announcing on Wednesday that as of Nov. 12, employees in Denmark will be required to show a valid corona passport at all large meetings, social arrangements and company fitness centers. The pharmaceutical company also announced that a vaccine mandate will come into force from Dec. 8 for its employees and project employees in the US.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Rumored GN purchase unlikely but not impossible, say analysts

A low value assessment, a high structural value, and no dominant shareholders make GN Group a reasonable investment case for international private equity firms and industrial players. But just how likely is it? Analysts reveal their best bets for what a GN acquisition could look like.

New CFO wants to shake things up at WSA

A mere month into her new job, Marianne Wiinholt, WS Audiology’s fifth chief financial officer since the firm was established through a merger in 2019, is heralding great structural changes.

Further reading

Related articles

Latest news

See all jobs